| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.41 | 2e-08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |